TrialInternational journal of hematology2013

JAK2 46/1 haplotype is associated with JAK2 V617F-positive myeloproliferative neoplasms in Japanese patients.

Mayumi Tanaka et al.PubMed ↗Publisher ↗

No numbers read from the abstract.